A large fraction of the drugs currently approved are derived from natural products which have always been a great source for new lead compounds offering new structural diversity
Ulrich Betz Head of Strategic Innovation and Research Portfolio Manageme..
Asian biotechnology companies lack of experience in pharmaceutical alliances can be quickly overcome by deliberate preparation careful identification of potential partners and anticipation of the due diligence process of partnering..
Oncology is currently one of the most exciting but demanding areas for developing successful brand strategies Companies entering smaller and niche markets in this area should clearly differentiate their products from competition to command and sustai..
Immunogenicity poses a risk that should be assessed during drug development as it possibly compromises drug safety and alters drug characteristics including pharmacokinetics and bioavailability Immunogenicity assessment strategies combine preclinical..
Immunotoxins comprise cellspecific targeting components coupled to cytotoxic agents Although clinical data are encouraging the problem of immunogenicity remains unsolved To allow repeated administration human immunotoxins with greatly reduced immunog..
In a changing market for clinical trials where fast recruitment of large patient numbers is of the essence Site Management Organisations SMOs operating as independent Contract Research Oorganisation CRO divisions offer some significant advantages in ..
With the increasing popularity of global and regional trials in Japan most global pharma companies are looking to develop as many compounds in Japan as possible Yet with limits to headcount increases companies face limited options to achieve their bu..
In an increasingly competitive marketplace the current organisational models for supply chains will no longer be effective A process excellence culture will enable an organisations resiliency and provide a competitive advantage to it in the future..
High shear homogenizing and low pressure homogenizing open new pathways for fine emulsions with narrow drop size distributions Their flexibility allows the introduction of exactly desired and validated shear forces..